Metabolically Healthy Obesity
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Obesity contributes to reduced life expectancy, impaired quality of life, and disabilities, mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis, and cancer. However, there is a large variation in the individual risk to developing obesity-associated comorbid diseases that cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the concept of metabolically healthy obesity (MHO). Although there is no clear definition, normal glucose and lipid metabolism parameters—in addition to the absence of hypertension—usually serve as criteria to diagnose MHO. Biological mechanisms underlying MHO lower amounts of ectopic fat (visceral and liver), and higher leg fat deposition, expandability of subcutaneous adipose tissue, preserved insulin sensitivity, and beta-cell function as well as better cardiorespiratory fitness compared to unhealthy obesity. Whereas the absence of metabolic abnormalities may reduce the risk of type 2 diabetes and cardiovascular diseases in metabolically healthy individuals compared to unhealthy individuals with obesity, it is still higher in comparison with healthy lean individuals. In addition, MHO seems to be a transient phenotype further justifying therapeutic weight loss attempts—even in this subgroup—which might not benefit from reducing body weight to the same extent as patients with unhealthy obesity. Metabolically healthy obesity represents a model to study mechanisms linking obesity to cardiometabolic complications. Metabolically healthy obesity should not be considered a safe condition, which does not require obesity treatment, but may guide decision-making for a personalized and risk-stratified obesity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hyperplasia, referring to an increase in the number of adipocytes, is associated with an increase in subcutaneous fat volume and protective signals, and is associated with MHO (50).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“On the contrary, hypertrophic adipocytes, in which existing adipocytes enlarge, is associated with increased dysfunction and MUHO (50), which contributes to IR and subsequent T2D (52, 53).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 7×
“8 Endocrine Reviews, June 2020, 41(3):1–16 Blüher Metabolically Healthy Obesity sex hormones may play a role in the transition from MHO to MUO.”
BackgroundInfluentialSelf-citationThe global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Cited by
Items 601–700 of 999
Sia, C., Ko, J., Zheng, H., Ho, A. F. W., Foo, D. C. G., Foo, L.-L., Lim, P. Z., Liew, B. W., Chai, P., Yeo, T. C., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1142078 · Cited by 3
Bouaziz, K., Belkaaloul, K., & Khéroua, O. (2023) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2023.100377 · Cited by 4
Obesity and Hypertension: Pathophysiology and Treatment
Hall, M. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., & Hall, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00037-2 · Cited by 6
Nematbakhsh, R., Hajhashemy, Z., Lotfi, K., Shahdadian, F., Rouhani, P., & Saneei, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-48056-x · Cited by 3
Comparing Methods for Induction of Insulin Resistance in Mouse 3T3-L1 Cells
Al-Jaber, H., Almuraikhy, S., Jabr, A. J., Yousuf, A., Anwardeen, N. R., Elrayess, M. A., & Al-Mansoori, L. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998263359231211044539 · Cited by 3
Ezeh, U. I., Chen, Y. I., Pall, M., Buyalos, R. P., Chan, J. L., Pisarska, M. D., & Azziz, R. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.030 · Cited by 6
Guzmán-García, J.-M., Romero‐Saldaña, M., Molina‐Recio, G., Álvarez-Fernández, C., Jiménez-Mérida, M. D. R., & Molina‐Luque, R. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.04.017 · Cited by 3
“11 However, people with MUO have a higher mortality than those in the non-obesity, metabolically healthy category (MHNO) , 3 as well as a higher prevalence of cardiovascular disease 9 than the latter, so that no degree of obesity is without risk.”
Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer
Fusco, S. A. D., Mocini, E., Gori, M., Iacoviello, M., Bilato, C., Corda, M., Luca, L. D., Marco, M. D., Geraci, G., Iacovoni, A., et al. (2024) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suae031 · Cited by 3
“25 The measurement that most significantly complements the informational value of BMI is the WC, 26 an indirect yet directly correlated indicator to VAT.”
BackgroundAmouzegar, A., Honarvar, M., Masoumi, S., Agahi, S., Azizi, F., & Mehran, L. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078701 · Cited by 4
Circulating proteomic profiles in women with morbid obesity compared to normal-weight women
Bertran, L., Rusu, E. C., Guirro, M., Aguilar, C., Auguet, T., & Richart, C. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105317 · Cited by 3
Ishfaq, F., Iqtadar, S., Lodhi, S., Kanwal, S., Amir, H., Ishfaq, A., & Ishfaq, A. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100140 · Cited by 3
Xu, R., Wang, C., Cong, H., & Wang, L. (2025) · Endocrine · doi:10.1007/s12020-025-04169-z · Cited by 4
“MHO is characterized by less ectopic fat and more leg fat, greater subcutaneous adipose tissue fl exibility, and beta-cell function, and better cardiorespiratory fi tness, which can result in a reduced risk for MACE [37, 38].”
Linder, A., Eggebrecht, T., Linder, N., Stange, R., Schaudinn, A., Blüher, M., Denecke, T., & Busse, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-87578-4 · Cited by 3
Self-citationBarbieri, D., Goicoechea, M., García‐Prieto, A., Delgado, A. B., Verde, E., Verdalles, Ú., de José, A. P., Carbayo, J., de Morales, A. M., & Luño, J. (2020) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2020.09.004 · Cited by 4
Karras, S. Ν., Koufakis, T., Dimakopoulos, G., Adamidou, L., Karalazou, P., Thisiadou, K., Bais, A. F., Tzotzas, T., Manthou, E., Makedou, K., et al. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105903 · Cited by 6
Folk Devils or Moral Entrepreneurs? Gap Bridging in the Social Studies of Pro-ana Communities
Mikhaylova, O. R. (2021) · Deviant Behavior · doi:10.1080/01639625.2021.1937753 · Cited by 3
“…which are shared in the form of stories by different social actors, can be considered contemporary legends, whereas being overweight predicts mortality only in combination with other ‘confounding factors’, for example chronic illnesses or a sedentary lifestyle (Blüher 2020; Phillips et al. 2013).”
BackgroundThe missing link between inflammation and arterial stiffness among different metabolic phenotypes
Canpolat, A. G., Demir, Ö., Şahin, M., Emral, R., & Çorapçıoğlu, D. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14727 · Cited by 3
Bariatric Surgery Outcomes in Patients with Latent Autoimmune Diabetes of the Adult
Guimarães, M., Pereira, S. S., Nora, M. C., & Monteiro, M. P. (2021) · Obesity Facts · doi:10.1159/000517588 · Cited by 4
Jin, J., Zhang, H., Liu, H., Zhu, C., Guo, Y., Wu, N., Xu, R., Dong, Q., & Li, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870341 · Cited by 3
“In the past half-century, the prevalence of obesity worldwide has almost tripled (2, 13).”
BackgroundConte, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_7 · Cited by 5
Hasparian, K. A., Kondratiuk, V. K., Trokhymovych, О. V., Kondratiuk, K. O., Nikitina, I. M., & Пономарьова, І. Г. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202110122 · Cited by 5
Michelsen, T. M., Skytte, H. N., Gunnes, N., Holven, K. B., Christensen, J. J., & Roland, M. C. P. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104397 · Cited by 2
Mao, D., & Li, B. (2025) · Children · doi:10.3390/children12040439 · Cited by 6
“Moreover, research has shown that pediatric patients with BMI-classified obesity do not consistently exhibit metabolic abnormalities such as hypertension, hyperglycemia, dyslipidemia, or insulin resistance [61, 62], which suggests the necessity for more comprehensive diagnostic measures.”
Suleman, S., Ängquist, L. H., Linneberg, A. R., Hansen, T., & Grarup, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-98507-w · Cited by 3
Rosero, R., Tamayo, M., Correa, R. R., Burguera, B. G., & Griebeler, M. L. (2025) · Obesity Science & Practice · doi:10.1002/osp4.70077 · Cited by 5
Zhao, C., Yang, Y., Yang, Y., Yang, W. H., Mu, L., & Jia, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1608603 · Cited by 3
“A 2020 Endocrine Reviews synthesis cataloged more than 30 published criteria sets, showing that prevalence of MHO can range from 6 to 75% depending on which metabolic, inflammatory or insulin-sensitivity thresholds are applied, complicating direct comparisons between MAO and MHO groups (7).”
Epicardial fat tissue in metabolically healthy and unhealthy obesity: culprit or bystander?
de Alteriis, G., Pugliese, G., Somma, C. D., Falco, A., Muscogiuri, G., Barrea, L., Laudisio, D., Zumbolo, F., ESPOSITO, R., Pucci, M., et al. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.25.04257-5 · Cited by 2
Wishlade, T., Wetzler, S. R., & Aiken, C. (2025) · AJOG Global Reports · doi:10.1016/j.xagr.2025.100527 · Cited by 2
Güneş, E., Güneş, M., Kaya, M. İ., Yüksel, M., Memet, S., Kibar, B., Kaya, C., Tufanoğlu, F. H., & Oral, B. (2025) · Endocrine · doi:10.1007/s12020-025-04355-z · Cited by 2
“It is evident that a single, uni fi ed de fi nition of obesity is inadequate for capturing the nuances of this complex phenomenon [19, 20].”
Tang, S., Li, D., Ma, Y., Zhao, Z., Peng, L., Liao, S., Ma, H., & Wei, H. (2025) · Biology · doi:10.3390/biology14091136 · Cited by 2
Watany, M. M., & Elhosary, M. M. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf124 · Cited by 2
Placental Morphology and Metabolomic Profile in Uncomplicated Metabolically Healthy Obese Pregnancy
Sarr, O., Rajagopaul, A., Zhao, S., Wang, X., Grynspan, D., Eastabrook, G. D. M., Li, L., Regnault, T. R. H., & de Vrijer, B. (2025) · Biomedicines · doi:10.3390/biomedicines13092149 · Cited by 2
Chwa, W. J., Rahmani, F., Dolatshahi, M., Commean, P. K., Kasani, S. H., Cai, L. T., Mukherjee, P., & Raji, C. A. (2025) · npj Dementia · doi:10.1038/s44400-025-00028-w · Cited by 4
Liu, L., Zhou, J., Guo, S., Lian, B., Zhang, H., Dong, Y., Liu, Y., Zhang, S., & Yin, C. (2025) · Pediatric Diabetes · doi:10.1155/pedi/9918136 · Cited by 2
Hu, C., Zhang, J., Lin, L., Jia, X., Wang, S., Zheng, R., Li, M., Xu, Y. H., Xu, M., Lin, H., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70249 · Cited by 4
“13,14 Nevertheless, BMI provides limited information about individual health.”
Impact of the 2025 Lancet Diagnostic Criteria on Obesity Treatment in the United States
Chumakova-Orin, M., Finucane, F. M., Chen, Y., & Juo, Y. (2025) · Clinical Obesity · doi:10.1111/cob.70050 · Cited by 5
Calderón‐Domínguez, M., Sánchez‐Muñoz, I., González‐Blázquez, R., Gil‐Ortega, M., Somoza, B., Solera, R. A., Fernández, P., Carrera, E., Valverde-Pozo, J., Larriva, M., et al. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00777-6 · Cited by 2
Anvarova, S., Narimova, G., Aliyeva, A., Khalimova, Z., & Nasirova, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1693509 · Cited by 3
Bánovčinová, A., Schusterová, I., Tóth, Š., Porubän, T., Pella, D., Dvorožňáková, M., & Fülöp, P. (2025) · Nutrients · doi:10.3390/nu17233715 · Cited by 2
Zhang, J., Yang, C., Dong, X., & An, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2599614 · Cited by 3
“…advanced metabolic dysfunction accompanied by compensatory physiological mechanisms or intensive medical interventions aimed at lipid control [38,39]; and [2] the paradox of dysfunctional adipose tissue, wherein severely obese individuals may exhibit impaired adipose tissue function, resulting…”
From the metabolic perspective of orbital fat: Can arachidonic acid turn “bad fat” into “good fat”?
Cheng, Y., Chen, S., Du, L., Yan, S., & Liu, G. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.11.018 · Cited by 2
Li, J., Liu, X., Ren, Z., Zhang, J., Wang, S., & Bai, H. (2025) · Medicine · doi:10.1097/md.0000000000046525 · Cited by 2
“[28] These findings underscore the inadequacy of BMI alone as a risk stratification tool and highlight the value of functional metabolic indices in cardio-vascular risk prediction.”
Ortiz, G. G. R., Granero, R., Maraver-Capdevila, L., & Aguirre-Quejada, A. (2026) · Nutrients · doi:10.3390/nu18010145 · Cited by 3
Cheng, X., Wang, J., Wang, J., Yin, J., Xing, X., & Cai, G. (2026) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-026-09495-5 · Cited by 2
“Participants were classified as metabolically healthy at baseline meeting all of the following criteria [17, 18]: (1) serum triglycerides ≤ 1.7 (mmol/L); (2) HDL-cholesterol concentration > 1.0 (mmol/L men) or > 1.3 (mmol/L women); (3) systolic blood pressure (SBP) ≤ 130 (mmHg) and diastolic blood…”
InfluentialJi, C., & Liu, F. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02168-3 · Cited by 2
“Potential factors such as different inclusion and exclusion criteria, study populations, and especially the strictness or otherwise of the definition of MHO [37, 38] can lead to inconsistencies in prevalence rates.”
Sheth, N. D., Shaker, I. A., & Ranade, J. (2026) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_314_25 · Cited by 2
“Prior studies have highlighted the presence of metabolically healthy individuals with isolated lipid abnormalities, cautioning against underestimating risk based solely on obesity or BP. [18,19] Class 2 characterized by normowaist but moderate‑systolic elevation (42”
Gao, Y., Guo, Z., Zhao, Y., Xi, X., Hou, G., Liu, L., & Zhang, D. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1761980 · Cited by 3
Li, F., Wang, Z., Qi, S., Xu, Y., & Shi, C. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.043083 · Cited by 3
Nam, Y., Yoon, E. C., & Yoon, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1778828 · Cited by 2
“In the general population, obesity is associated with a worse prognosis due to several factors, including an increased risk of comorbidities such as hypertension, diabetes, cardiovascular diseases, metabolic syndrome, reduced immune function, and chronic inflammation (46).”
Anti-Angiogenic Features of Endostatin in Obesity, Liver Fibrosis, and Hepatocellular Carcinoma
Grewal, T., & Buechler, C. (2026) · Biomedicines · doi:10.3390/biomedicines14030734 · Cited by 3
“In so-called “metabolically healthy obesity”, it is suggested that the remodelling of the extracellular matrix (ECM) occurs in a manner required for the healthy expansion of subcutaneous fat depots [21,22].”
SLIT3 fragments orchestrate neurovascular expansion and thermogenesis in brown adipose tissue
Serdan, T. D. A., Cervantes, H. E., Frank, B., Gargey, A., Tian, Q., Hope, D., Choi, C. H. J., Hoffmann, A., Ghosh, A., Wolfrum, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70310-9 · Cited by 6
Self-citationNetwork topology of the gut microbiome associates with metabolic health in obesity
Lacruz-Pleguezuelos, B., Perez-Cuervo, A., Coleto-Checa, D., Bazán, G. X., Romero-Tapiador, S., Freixer, G., Fernández-Cabezas, J., Aguilar-Aguilar, E., Martín‐Segura, A., Cárdenas-Roig, N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72588-1 · Cited by 5
“Therefore, current research focuses on delaying this transition as much as possible to maintain patient quality of life, cardiometabolic health, and noncommunicable disease-free years 1,6 .”
InfluentialWang, Z., He, Y., Li, L., Zhang, M., Ruan, H., Zhu, Y., Wei, X., Wei, J., Chen, X., & He, S. (2022) · BMC Public Health · doi:10.1186/s12889-022-14062-3 · Cited by 2
Mehrabi, F., Mahani, F., Cheraghi, L., Kheradmand, A., Azizi, F., & Amiri, P. (2023) · Obesity Facts · doi:10.1159/000529596 · Cited by 2
Seo, M.-W., Lee, J. M., & Jung, H. C. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.03.002 · Cited by 3
Giunta, G. A., Cutine, P. D., Iztueta, M. F. A., Pirola, D. A., Messina, N., Helman, L., Acuña, M. I. R., Kraselnik, A., Brandani, L., & Badimón, J. J. (2023) · British Journal of Cardiology · doi:10.5837/bjc.2023.017 · Cited by 2
Dahlmann, N., & Klingmüller, D. (2023) · Archives of Internal Medicine Research · doi:10.26502/aimr.0147 · Cited by 2
The evolution of body composition assessment: from body mass index to body composition profiling
Kiseleva, E. V., Pigarova, E. A., & Mokrysheva, N. G. (2023) · FOCUS Endocrinology · doi:10.15829/1560-4071-2023-13 · Cited by 2
Mechanisms and Research Progress Relatedto Obesity and Metabolic Syndrome
熊, 昱. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1392036 · Cited by 2
Obesity Phenotypes and Dental Calculus in Young Adults: CHIEF Oral Health Study
Liu, W.-N., Huang, R., Cheng, W., Wang, H.-S., Huang, C.-M., Chen, H.-H., Tsai, K., & Lin, G. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303245065230925060301 · Cited by 2
Leis, A. M., Jackson, E. A., Baylín, A., Barinas‐Mitchell, E., Khoudary, S. R. E., & Karvonen-Gutierrez, C. A. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002273 · Cited by 2
Ruyatkin, D. S., Ruyatkina, L. A., & Щербакова, Л. В. (2023) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2023-7-3-37-53 · Cited by 2
A Mini Review Study on Mitochondria and Citrate Synthase
Alzahrani, S., Alharbi, W. K., Khawaji, H., Elashmony, S. M., & Alhindi, Y. Z. (2023) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/gzuup6dkxv · Cited by 2
Zhu, Y., Yin, Y., Huang, F., Liu, Y., Xia, Y., Zhang, M., Wang, Y., & Jin, L. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.20 · Cited by 2
Zhan, H., Qichun, C., Liu, T., Shi, Y., Pei, J., Zou, L., & Wang, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s447847 · Cited by 2
“19 In this study, patients with the MHO phenotype had lower CSA muscle of paraspinal muscle, however there was no significant difference in paraspinal muscle fat area between the two groups.”
BackgroundUzdil, Z., Macit, M. S., & Us, N. C. (2024) · Clinical Science of Nutrition · doi:10.62210/clinscinutr.2024.83 · Cited by 2
Borra, V., Jain, A., Borra, N., Kattamuri, L. P. V., Senapati, S. G., Machineni, N. V. K., Kukkala, S., Ramasahayam, K., Prajapati, K., Vyas, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102820 · Cited by 2
The Prevalence of overweight nurses in Italy: a systematic review
Brusini, A., Tersigni, S., Curatolo, D., Trepiccione, M. G., & Papotti, B. (2024) · infermieristica journal · doi:10.36253/if-2428 · Cited by 2
Biochemistry and laboratory diagnosis of obesity
Milinković, N., Bogavac‐Stanojević, N., Vekić, J., Jovičić, S. Ž., & Kotur‐Stevuljević, J. (2024) · Arhiv za farmaciju · doi:10.5937/arhfarm74-50458 · Cited by 3
Barbaro, F., Conza, G. D., Quartulli, F. P., Quarantini, E., Quarantini, M., Zini, N., Fabbri, C., Mosca, S., Caravelli, S., Mosca, M., et al. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1374135 · Cited by 2
“This is a condition where the body mass index (BMI) is in the obesity range associated with hyperinsulinemia, hyperglycemia, dyslipidemia, hypertension, and cardiovascular manifestations, as opposed to the metabolically healthy obesity, where these complications are absent (Bluher, 2020).”
BackgroundCho, S., Shin, A., Choi, J., Lee, J., & Kang, D. (2024) · Epidemiology and Health · doi:10.4178/epih.e2024073 · Cited by 4
Treatment of Obesity Before, During, and After Pregnancy: Time for Obstetricians to Get Involved
Gustafson, D., Al-Sayyed, F., & Minkoff, H. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001329 · Cited by 2
Das, S., Kumar, S., & Choudhury, A. B. (2024) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20243696 · Cited by 2
Scott, S., Peterson, R. L., North, S. J., Merrick, J., Petranovich, C. L., Wilson, P. E., Lantagne, A., & Simpson, T. S. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsae102 · Cited by 2
Coşkun, A. B., Yılmaz, F. Ç., & Açık, M. (2025) · Chronobiology International · doi:10.1080/07420528.2024.2445732 · Cited by 2
“However, in recent years, the existence of heterogeneity in cardiometabolic risk factors among obese individuals has come to light, and some of these individuals have been reported to be more resistant to metabolic and inflammatory fibrinolytic dysfunction (Blüher 2020; Stefan et al. 2013).”
Polyphenols from Edible Brown Seaweeds Against Adiposopathy-Associated Metabolic Ailments
Kumar, S. A., Sharma, S. D., Vaani Katyal, R., & Ahmed, C. Y. G. (2025) · Food Reviews International · doi:10.1080/87559129.2025.2451097 · Cited by 2
Multiomics unravels the complexity of male obesity: a prospective observational study
Papadakis, G. E., Favre, L., Zouaghi, Y., Vionnet, N., Niederländer, N. J., Adamo, M., Acierno, J. S., Berdous, D., Boizot, A., Meylan, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06040-7 · Cited by 3
Rodríguez‐Casado, A., Álvarez, M., Merino, J. J., Tolédano, A., & Tolédano, A. (2025) · Current Alzheimer Research · doi:10.2174/0115672050375461250325074826 · Cited by 5
Pingili, A., Desai, R., Vempati, R., Vemula, M., Lakkimsetti, M., Madhavaram, H. J., Nanjundappa, A., Singh, S., Sunkara, P., & Gummadi, J. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i4.105842 · Cited by 2
Cheng, Q., Na, K., Chun-sheng, X., Peng, H., Lin, X., Chen, J., Li, Y., Wu, D., Du, M., & Wang, X. (2025) · Food & Function · doi:10.1039/d4fo06132b · Cited by 2
The Role of the BMI ≥ 40 kg/m2 Criterium in ASA-PS Classification for Metabolic Surgery
van Ede, E. S., Nienhuijs, S. W., Buise, M. P., & Bouwman, R. A. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08118-7 · Cited by 3
“This so-called metabolically healthy obesity is characterized by less visceral adipose tissue and less inflammation, and a better cardiorespiratory fitness than patients with metabolically unhealthy obesity [5, 7].”
InfluentialBody mass index and its association with clinical outcomes in acute liver failure
Krishnan, A., Khan, S., Gips, J. R., Alqahtani, S. A., Vaidya, D. M., Liu, Y., Kim, A., Su, A., Gurakar, A. O., Hamilton, J. P., et al. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i30.109212 · Cited by 2
Prävention, Remission oder Verzögerung der Typ-2-Diabetes-Manifestation – Teil 1
Landgraf, R. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-0872-6365 · Cited by 3
Gearing up for the Future: Mitigating Dysregulated Inflammation in Aging and Facets of Obesity
Xu, W., & Larbi, A. (2020) · Immunometabolism · doi:10.20900/immunometab20210002 · Cited by 2
Numao, S., So, R., Matsuo, T., Nakagaichi, M., & Tanaka, K. (2021) · Journal of Physical Therapy Science · doi:10.1589/jpts.33.137 · Cited by 2
Zimmermann, S., Vogel, M., Mathew, A., Ebert, T., Rana, R., Jiang, S., Isermann, B., & Biemann, R. (2022) · Nutrients · doi:10.3390/nu14153060 · Cited by 3
Ectopic Fat and Cardiac Health in People with HIV: Serious as a Heart Attack
Hyatt, A. N., & Lake, J. E. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00620-2 · Cited by 2
Gut Microbiota and Fear Processing in Women Affected by Obesity: An Exploratory Pilot Study
Scarpina, F., Turroni, S., Mambrini, S. P., Barone, M., Cattaldo, S., Mai, S., Prina, E., Bastoni, I., Cappelli, S., Castelnuovo, G., et al. (2022) · Nutrients · doi:10.3390/nu14183788 · Cited by 3
Lee, H. G., Hur, J., Won, J. P., & Seo, H. G. (2023) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00408-4 · Cited by 2
“Obesity is defined as the abnormal or excessive fat accumulation in the body, which poses a health risk (Bluher 2020).”
Relationships between obesity markers and bone parameters in community-dwelling older adults
Lemoine, L., Buckinx, F., Aïdoud, A., Leroy, V., Fougère, B., & Aubertin‐Leheudre, M. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02673-8 · Cited by 3
“Around 20% of obese people are metabolically healthy [20], and some researchers use the term “metabolically healthy obesity” [21].”
BackgroundZhang, Y., Xue, J., Li, S., Yang, H., & Kang, C. S. (2024) · HORMONES · doi:10.1007/s42000-024-00568-5 · Cited by 2
Metabolically "healthy" obesity in postmenopausal women: Unmasking the cardiovascular risk
Koros, R., Domouzoglou, E. M., & Papafaklis, M. I. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i9.110228 · Cited by 2
Obesity Adversely Affects Dietary Metabolism: Time to Inform Guidelines?
Gupta, R., & Yadav, A. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.045359 · Cited by 2
Wu, H., Lin, X., Cheng, C., Jiang, H., Iqbal, J., Liu, J., & Zhou, H. (2023) · NMR in Biomedicine · doi:10.1002/nbm.4985 · Cited by 1
“It is a useful, simple and easy to apply measurement, but it does not adequately discriminate metabolic disorders from obese patients.(2) Indeed, the classification of obesity has been challenged and includes metabolically unhealthy obesity and metabolically healthy obesity according to the risk of metabolic disorders…”
BackgroundFat as insurance, leanness as bodily display: did Ronald Reagan make us fat?
Haig, D. (2023) · Journal of Bioeconomics · doi:10.1007/s10818-023-09338-6 · Cited by 1
“Obesity is correlated with type 2 diabetes and hypertension but obese individuals who have normal lipid and glucose parameters without hypertension are said to exhibit ‘metabolically healthy obesity’ (Blüher, 2020).”
Association of metabolic health and obesity with coronary heart disease in adult cancer survivors
Kim, K., Giovanna, E. D., Jung, H.-Y., Bethineedi, L. D., Jun, T. J., & Kim, Y. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14161 · Cited by 3
“11 This may be due to several mechanisms, including increased oxidative stress vascular calcification resulting the activation of vascular bone morphogenetic protein.”
BackgroundWang, Q., Chen, L., Zhang, J., Liu, Y., Jin, Y. C., Jian Xin, W. U., & Ren, Z. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae012 · Cited by 1
Kim, J., Kang, S., & Kang, H. (2024) · Journal of Men s Health · doi:10.22514/jomh.2024.053 · Cited by 1
Roca-Rivada, A., Cruzeiro, M. D., Denis, R., Zhang, Q., Rouault, C., Rouillé, Y., Launay, J., Cruciani‐Guglielmacci, C., Mattot, V., Clément, K., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168418 · Cited by 1
Shang, W., Kong, J., Zhang, M., Chen, T., Zhao, L., Wang, K., & Yang, Q. (2024) · Metabolites · doi:10.3390/metabo14090468 · Cited by 1
Metadata
- Authors
- Blüher, M.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Blüher, Matthias
- ORCID
- Blüher, Matthias
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-03-04
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7098708
- OpenAlex
- W3009496837
- Cited by
- 1,090
- References
- 123
- Citations by year
- 2026: 197 · 2025: 222 · 2024: 213 · 2023: 162 · 2022: 155 · 2021: 105 · 2020: 35
- FWCI
- 86.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (209933838)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- metabolically healthy obesity, obesity, cardiometabolic risk, type 2 diabetes, cardiovascular disease, insulin sensitivity, beta-cell function, ectopic fat, visceral fat, liver fat, leg fat, cardiorespiratory fitness, weight loss, obesity treatment, risk stratification
- MeSH terms
- Obesity, Metabolically Benign, Cardiometabolic Risk Factors, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.